INVIVOSCIENCES, INC.
Medtech · Private
AI-assisted diagnostic platform that analyzes echocardiography and catheterization data to stratify heart failure phenotypes and identify patient subgroups
- Grants
- $4.5M
- 13 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $679K
- 6 awards · Health and Human S
- #359 of 4531 in medtech
- Patents
- 7
- 2 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142016201820202022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Igf::ot::igf Phenotypic Cardiotoxicity Screening With Human 3D Heart Tissues | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Engineered tissue-based, high-throughput compound profiling | $10,764 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Research Services For 3 Dimensional Cardiac Physiology Analysis System To Measure Chemical Induced Cardiac Toxicity Using Human Cardiomyocytes | $24,000 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Cardiac Physiology Analysis Services | $24,990 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf High Resolution Image Analysis Of Calcium Transient And Action Potential Of Induced Pluripotent Stem Cell-derived Human Cardiomyocytes (ipsc-cms, From Both Male And Female | $30,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Mass Production Of Personalized Human Engineered Heart Tissues | $349,446 | |
| Federal grant | Department of Health and Human Services · Phase I · Engineered Tissue Based Phenotypic Screening of Mixture based Libraries | $350,000 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf 3 Dimensional Cardiac Physiology Analysis | $24,990 | |
| Federal grant | Department of Health and Human Services · Phase I · Engineered Tissue Based Phenotypic Screening of Mixture based Libraries | $350,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Engineered Tissue Based Phenotypic Screening of Mixture based Libraries | $58,660 | |
| Federal grant | Department of Health and Human Services · Phase I · An Aging Heart Model for Drug Discovery | $177,723 | |
| Federal grant | Department of Health and Human Services · Phase I · An Aging Heart Model for Drug Discovery | $176,368 | |
| Federal grant | Department of Health and Human Services · Phase I · An Aging Heart Model for Drug Discovery | $139,836 | |
| Federal grant | Department of Health and Human Services · Phase II · HLS-Cardiac Safety AI Trained Human Heart and Micro Heart Model | $349,385 | |
| Federal grant | Department of Health and Human Services · Phase I · Aging Heart Modeling with Progeria iPSCs | $288,459 | |
| Federal grant | Department of Health and Human Services · Phase II · HLS-Cardiac Safety AI Trained Human Heart and Micro Heart Model | $881,652 | |
| Federal grant | Department of Health and Human Services · Phase II · HLS-Cardiac Safety AI Trained Human Heart and Micro Heart Model | $861,204 | |
| Federal contract | Department of Health and Human Services · The Development Of Mechanism-based Adult Stem Cell Treatments To Combat Aging Pathologies | $349,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Diagnostic Tools for Targeted Heart Failure Treatments | $493,728 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 356 | BIOPTIGEN, INC. | $686K | $1.5M |
| 357 | ISOPLEXIS CORPORATION | $684K | $127M |
| 358 | TearScience, Inc. | $681K | $59M |
| 359 | INVIVOSCIENCES, INC. | $679K | — |
| 360 | Sonica LLC | $656K | — |
| 361 | Beta Bionics, Inc. | $654K | $222M |
| 362 | VINDHYA DATA SCIENCE INC. | $653K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Three Dimensional Tissues For High-throughput Assaysgranted
- Automated Cell Culture System with Heated, Angled Adapter and Methodapplication
- Automated Cell Culture System And Methodgranted
- Systems And Methods For Treating Heart Failure With Preserved Ejection Fractionapplication
- Systems And Methods For Treating Heart Failure With Preserved Ejection Fractionapplication
- Systems And Methods For Treating Heart Failure With Preserved Ejection Fractionapplication
- Automated Cell Culture System And Methodapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.